Patent · US Active

Highly concentrated formulations of soluble Fc receptors

US10226504B2 · kind B2 · utility

1Cited by

1References

35Claims

0Family size

Assignee

SUPPREMOL GMBH · DE

Inventors

Peter Sondermann · Stockdorf, DE
Thomas Pohl · Holzgerlingen, DE

Key dates

Filing date	Apr 16, 2014
Grant date	Mar 12, 2019
Priority date	—
Expiry date	Apr 16, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel formulations of soluble Fc receptors and especially to formulations containing high concentrations of soluble FcγRIIB receptor. The invention further relates to the use of such formulations as pharmaceutical compounds for the treatment of autoimmune diseases, infections and other conditions where the immune system is involved.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.